BETHLEHEM, Pa., July 12 /PRNewswire/ — B. Braun Medical
Inc. (B. Braun) announced today the availability of large volume
heparin infusion solutions.
(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO
)
(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO
)
Based on the new United States Pharmacopeia (USP) standards for
heparin products released by the U.S. Food and Drug Administration
(FDA) in October 2009, changes to B.
Braun’s large volume heparin IV solutions include a modification of
the reference standard for the drug’s unit dose.
The following heparin infusion solutions are now available from
B. Braun without restriction:
- P5671, Heparin Sodium (40 U/mL) in 5% Dextrose Injection (500
mL EXCEL® Plastic Container) - P5771, Heparin Sodium (50 U/mL) in 5% Dextrose Injection (500
mL EXCEL® Plastic Container) - P5872, Heparin Sodium (100 U/mL) in 5% Dextrose Injection (250
mL EXCEL® Plastic Container)
In addition, the following heparin infusion solutions remain
available on allocation:
- P87
‘/>”/>
SOURCE
